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Aims
The Fluid Lavage in Open Fracture Wounds (FLOW) trial was a multicentre, blinded,
randomized controlled trial that used a 2 × 3 factorial design to evaluate the effect of
irrigation solution (soap versus normal saline) and irrigation pressure (very low versus low
versus high) on health-related quality of life (HRQL) in patients with open fractures. In this
study, we used this dataset to ascertain whether these factors affect whether HRQL returns
to pre-injury levels at 12-months post-injury.

Patients and Methods
Participants completed the Short Form-12 (SF-12) and the EuroQol-5 Dimensions (EQ-5D) at
baseline (pre-injury recall), at two and six weeks, and at three, six, nine and 12-months postfracture. We calculated the Physical Component Score (PCS) and the Mental Component
Score (MCS) of the SF-12 and the EQ-5D utility score, conducted an analysis using a multilevel generalized linear model, and compared differences between the baseline and 12month scores.

Results
We found no clinically important differences between irrigating solutions or pressures for
the SF-12 PCS, SF-12 MCS and EQ-5D. Irrespective of treatment, participants had not
returned to their pre-injury function at 12-months for any of the three outcomes (p < 0.001).

Conclusion
Neither the composition of the irrigation solution nor irrigation pressure applied had an
effect on HRQL. Irrespective of treatment, patients had not returned to their pre-injury HRQL
at 12 months post-fracture.
Cite this article: Bone Joint J 2018;100-B:88–94.

Open fractures are debilitating injuries frequently complicated by infection and problems
associated with wound and fracture healing.1-3
Their initial management includes thorough
irrigation and debridement to remove debris
and necrotic tissue.4 There has been uncertainty
over the choice of irrigating pressure and solution on both the rate of complications and
patients’ health-related quality of life (HRQL)
after open fractures.4-6 Used in conjunction with
clinical outcomes, HRQL is highly relevant for
the evaluation of fracture treatment and there
has been an increase in its use in fracture trials.7
The Fluid Lavage in Open Fracture Wounds
(FLOW) trial was a prospective, multicentre,
randomized controlled trial that evaluated the
effect of irrigation solution and pressure on
rates of re-operation in 2447 adult patients.3,8
Patients were randomized to one of three irri-

gating pressures: very-low pressure (1 psi to
2 psi), low pressure (5 psi to 10 psi), or high
pressure (> 20 psi), and one of two irrigating
solutions: 0.45% solution of castile soap (Castile Soap, Triad Medical, Hartland and Aplicare Inc., Meriden, Connecticut) or sterile
normal saline alone. The primary outcome was
a composite of re-operation, defined as surgery
within 12 months of the initial procedure to
treat infection at the operative site, management of wound-healing problems and promotion of bone healing. The assessment of HRQL
for 12 months post-fracture was an a priori
planned part of statistical analysis.8 In the current study, we aimed to determine: the impact
of the composition of the irrigation solution
and pressure of its delivery on HRQL and if
patient HRQL returns to pre-fracture levels by
12-months post-fracture.
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Table I. Patient characteristics and surgical and peri-operative management
HRQL cohort, n = 1860

Total FLOW cohort, n = 2447

45.4 (17.6), n = 1860
45.2 (17.8)*
Mean age (yrs) (SD)
Gender, n (%)
Male
1273/1860 (68.4)
1680/2428 (69.2)
Female
587/1860 (31.6)
748/2428 (30.8)
Current smokers, n (%)
614/1857 (33.1)
777/2405 (32.3)
Work-related injuries, n (%)
295/1859 (15.9)
349/2419 (14.4)
Mechanism of injury, n (%)
Motor vehicle accident (driver/passenger)
431/1860 (23.2)
613/2428 (25.2)
Motor vehicle accident (pedestrian)
197/1860 (10.6)
304/2428 (12.5)
Motorcycle accident
330/1860 (17.7)
414/2428 (17.1)
All-terrain vehicle accident
42/1860 (2.3)
47/2428 (1.9)
Crush injury
93/1860 (5.0)
116/2428 (4.8)
Fall from standing
202/1860 (10.9)
261/2428 (10.7)
Fall from height
352/1860 (18.9)
422/2428 (17.4)
Twist
25/1860 (1.3)
26/2428 (1.1)
Direct trauma (penetrating)
64/1860 (3.4)
74/2428 (3.0)
Direct trauma (blunt)
117/1860 (6.3)
141/2428 (5.8)
Explosion
1/1860 (0.1)
2/2428 (0.1)
Bicycle accident
5/1860 (0.3)
6/2428 (0.2)
Plane crash
1/1860 (0.1)
1/2428 (0.04)
Other
0/1860 (0.0)
1/2428 (0.04)
Major concomitant trauma, n (%)
Head injury
103/1860 (5.5)
145/2429 (6.0)
Chest injury
124/1860 (6.7)
187/2429 (7.7)
Intra-abdominal injury
67/1860 (3.6)
95/2429 (3.9)
Any of the above
233/1860 (12.5)
328/2429 (13.5)
Gustilo Type, n (%)
Type I
463/1857 (24.9)
639/2419 (26.4)
Type II
703/1857 (37.9)
899/2419 (37.2)
Type IIIA
526/1857 (28.3)
649/2419 (26.8)
Type IIIB
165/1857 (8.9)
232/2419 (9.6)
Location of fracture, n (%)
Arm
554/1860 (29.8)
758/2428 (31.2)
Leg
1306/1860 (70.2)
1670/2428 (68.8)
Hours to first incision from injury, median (IQR)
10.0 (6.4 to 15.9), n = 1832
9.8 (6.4 to 15.9), n = 2374
Surgical preparation solution, n (%)
Iodine or providone-iodine
1000/1852 (54.0)
1394/2413 (57.8)
Chlorhexidine
930/1852 (50.2)
1100/2413 (45.6)
Alcohol
294/1852 (15.9)
436/2413 (18.1)
Other
11/1852 (0.6)
14/2413 (0.6)
Definitive fixation, n (%)
Intramedullary nail
635/1860 (34.1)
821/2422 (33.9)
External fixator
33/1860 (1.8)
59/2422 (2.4)
Plate
962/1860 (51.7)
1218/2422 (50.3)
Other internal fixation
221/1860 (11.9)
308/2422 (12.7)
Other
9/1860 (0.5)
16/2422 (0.7)
*the ages of four patients in the FLOW cohort were not known. Mean age was calculated with n = 2443
HRQL, health-related quality of life; FLOW, Fluid Lavage in Open Fracture Wounds; IQR, interquartile range

Patients and Methods
FLOW trial. Details of trial methodology and primary outcome results have previously been published.3,8 Research
Ethics Board approval for the trial was obtained at the coordinating centre (McMaster University) (REB: 08-268)
and at each clinical site. The trial was prospectively registered at clinicaltrials.gov (NCT00788398).
HRQL. As a secondary outcome, patients enrolled in the
FLOW study were asked to complete the 12-Item Short
Form Health Survey (SF-12)9 and the EuroQol-5 Dimensions Questionnaire (EQ-5D)10 on recruitment to the trial
VOL. 100-B, No. 1, JANUARY 2018

(being asked to rate their pre-injury state), at two and six
weeks, and at three, six, nine and 12-months postinjury.11
The SF-12 physical (PCS) and mental component scores
(MCS) and EQ-5D index score were calculated according
to the developers’ recommendations. In our main analyses, we included patients where the SF-12 PCS, the SF-12
MCS or the EQ-5D score could be calculated for at least
one follow-up visit between two weeks and 12 months.
Sample size. Sample size for the HRQL analysis was a factor in the development of the FLOW protocol.8 We consid-
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Fig. 1
Short Form (SF)-12 scores (physical component score (PCS) and mental component score (MCS)) over time by solution.

ered an important difference in SF-12 to correspond to a
moderate effect as described by Cohen12 and noted the minimally important difference in the SF-12 reported by Ware
et al.9 In both cases, the value is 0.5 SD, equivalent to a fivepoint difference in the score. Specifying an α-level of 0.01
and a β-level of 0.20 (study power = 0.80), we required a
sample of at least 405 patients (135 in each of three
groups).
Initial sample size calculations for the EQ-5D were based
on previous literature suggesting that a 0.03 to 0.04 incremental change in the Health Utilities Index (HUI)13 represents a patient-important difference,14 and that the EQ-5D
correlates well with the HUI.15 We needed to recruit at least
329 patients in each of the three groups (α-level = 0.01,
β = 0.20, difference = 0.04, σ = 0.15).
Data analysis. Our main analyses were based on multi-level
generalized linear models, each comprising three levels (the
clinical site, patient and time of HRQL assessment (i.e.
visit)). We included the following independent variables:
nature of the irrigation solution, pressure of irrigation, time
point, baseline HRQL score and type of fracture (Gustilo
type I/II vs. type III).16
Given that the FLOW trial evaluated both the pressure of
and solution used for irrigation in the same patient population, we first ran the above model with an additional solution by a pressure interaction term, to identify any
interaction between the two treatment factors. We planned
a priori to remove from the model any interaction terms
that were not significant.

Follow us @BoneJointJ

Our final model for SF-12 PCS included the following
independent variables: randomized solution, randomized
pressure, time of HRQL assessment, pre-injury SF-12 PCS,
fracture type and interaction of time of HRQL assessment
by fracture type.
None of the interactions were significant in the analysis
of the SF-12 MCS. The model therefore included: solution,
pressure, time point, pre-injury SF-12 MCS and fracture
type. The interaction of time point by fracture type was the
only significant interaction term in the model for the EQ5D. This model therefore included solution, pressure, time
point, pre-injury EQ-5D score, fracture type and the interaction of time point by fracture type.
In addition to our main analysis, we performed an
adjusted analysis that added factors to these models. These
factors were: age, arm versus leg injury, postoperative fracture gap, initial method of internal fixation and severity of
wound contamination.
We also conducted two a priori subgroup analyses for
the SF-12 PCS, SF-12 MCS and EQ-5D scores, which were
fracture type (Gustilo Type I or II versus Gustilo Type III);16
and fracture location (arm versus leg).
The mean scores and SDs for the SF-12 PCS, SF-12 MCS
and EQ-5D were plotted over time by solution treatment
group and pressure treatment group. Mean differences
between the baseline (pre-injury) SF-12 PCS, SF-12 MCS
and EQ-5D scores and the corresponding 12-month
scores were calculated and compared using paired t-tests.
A p-value < 0.05 was considered statistically significant.
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Fig. 2
Short Form (SF)-12 scores (physical component score (PCS) and mental component score (MCS)) over time by pressure.

Patient demographics. A total of 1860 patients were

included, 1850 of whom completed the SF-12 and 1833 the
EQ-5D. The patient demographics and injury characteristics are similar to the overall FLOW cohort (Table I).3
Mean age was 45.4 years (SD 17.6) and most (n = 1273,
68.4%) were men.

Results
Most patients had a leg injury (n = 1306, 70.2%) and
underwent definitive fixation with a plate (n = 962, 51.7%)
or intramedullary nail (n = 635, 34.1%).
HRQL by irrigation pressures and solutions. We did not find
any significant differences in SF-12 PCS, SF-12 MCS or
EQ-5D utility scores between soap and saline or between
the three irrigation pressure groups over the one-year follow-up period (Figs 1 to 3). Our adjusted analyses did not
show any significant differences when compared with the
main analyses, so unadjusted analyses are presented. We
did not find subgroup effects on any outcome measure of
fracture type or location.
In our analysis of the SF-12 PCS, we found a significant
interaction (p = 0.032) between solution and pressure. As
both variables had been included in the same model, we
also included interaction terms between solution and time,
VOL. 100-B, No. 1, JANUARY 2018

and between pressure and time. In this model, the interaction was still significant (p = 0.032) but the interactions
between time point and solution, and between time point
and pressure were not significant (p = 0.88 and p = 0.54,
respectively).
In order to evaluate the magnitude and nature of the
interaction between pressure and solution, we examined
the effect of solution within each level of pressure, and the
effect of pressure within each level of solution (Table II).
Since this interaction was an unexpected finding, we sought
to objectively evaluate its credibility. We elected to adapt
criteria that have previously been used to assess the credibility of a sub-group analysis17 to determine if our observed
interaction was believable. Based upon the application of
these criteria, we determined that this finding had low credibility (Table III).
HRQL at one-year post-injury. One year post-injury, most
patients had not regained their pre-injury HRQL by any of
the three outcome measures (p < 0.001). Patients’ mean SF12 PCS at one year was 10.01 (95% confidence interval
(CI) 9.38 to 10.64) points lower than their pre-injury score,
and their mean SF-12 MCS was 2.61 (95% CI 1.97 to 3.25)
points lower than prior to injury. Patients’ EQ-5D mean
utility scores were 0.15 (95% CI 0.14 to 0.16) lower than
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Fig. 3
EuroQol-5 Dimensions (EQ-5D) utility scores over time by solution and by pressure.

pre-injury. At one year, patients had returned to 81% of
their PCS, 95% of their MCS and 84% of their ED-5D utility score.

Discussion
We found no differences between irrigation pressures in the
SF-12 PCS, SF-12 MCS and EQ-5D utility score. This echoes the findings of our primary study. Analysis of the SF-12
and the EQ-5D did not capture the difference between the
composition or pressure of the delivery system for the irrigation solutions which was seen in our primary study. This
may have been because the outcome measures were not sufficiently responsive to capture the relatively small differences in HRQL resulting from only 41 more patients
undergoing re-operation in the soap group when compared
with the saline group.
In our analysis of the SF-12 PCS, the significant interaction (p = 0.032) between solution and pressure was unexpected, given that the initial FLOW analysis had found no
such interaction. The size of the interaction was relatively
small, constituting less than half of the minimum important
difference of five points for the SF-12 PCS. No such interFollow us @BoneJointJ

action was seen with the SF-12 MCS, for the EQ-5D utility
score, or in the re-operation rate in the original study. There
is no basic scientific rationale to support the existence of
such an interaction. Consequently, based on the application
of the adapted criteria, we concluded that the observed
interaction was not highly plausible, and was most likely a
spurious finding.
We found that patients with open fractures had not
returned to their pre-injury status at one-year post-injury.
This is in keeping with the results of the Study to Prospectively Evaluate Reamed Intramedullary Nails in Tibial
Fractures (SPRINT) trial, which also reported a reduction
of 10 points in the PCS of the SF-36 over the same time
period in open and closed tibial fractures.19 The EQ-5D
scores were 0.15 points lower at one year, which also represents a clinically important difference.11 The SF-12 MCS,
by contrast, was 2.66 points lower and hence not a clinically important difference. These findings are also consistent with the results of the SPRINT trial, which found the
SF-36 MCS to be approximately 2 points lower at one
year.19 Similarly, a recent study of functional recovery in
patients with tibial fracture reported that HRQL had not
THE BONE & JOINT JOURNAL
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Table II. Effect of treatment group on Short Form-12 physical component scores (PCS) at 12 months
Mean difference between 12-month PCS (95% CI)*
At high pressure
Soap vs saline

1.18 (0.02 to 2.33)

At low pressure
Soap vs saline

0.45 (-0.71 to 1.61)

At very low pressure
Soap vs saline

-0.99 (-2.16 to 0.18)

With soap
High vs low
High vs very low
Low vs very low

-0.12 (-1.28 to 1.04)
0.51 (-0.64 to 1.67)
0.63 (-0.53 to 1.79)

With saline
High vs low
High vs very low
Low vs very low
*
from the main 3-level model
CI, confidence interval

-0.84 (-2.00 to 0.31)
-1.65 (-2.82 to -0.48)
-0.81 (-1.98 to 0.36)

Table III. Assessment of credibility of interaction between pressure and solution for Short Form (SF)-12 physical component scores (PCS)
Criteria*

Assessment

Is the interaction variable a characteristic measured at baseline or after
Measured at the time of randomisation
randomization?
Is the effect suggested by comparisons within rather than between studies?Yes, it is suggested by comparisons within a single study rather than
between studies
Was the hypothesis specified a priori?
Our a priori hypothesis was that there would be an interaction between
pressure and solution
Was the direction of the interaction effect specified a priori?
We were unable to find a compelling reason to specify a direction of a
possible effect modification
Was the interaction effect one of a small number of hypothesized effects
We looked at the following three interactions: randomized solution with
tested?
randomized pressure, randomized solution with time of HRQL assessment and randomized pressure with time of HRQL assessment
Does the interaction test suggest a low likelihood that chance explains
We obtained p = 0.032 for the interaction term, which suggests a low
the apparent subgroup effect?
likelihood that chance explains the apparent effect
Is the significant interaction effect independent?
The interaction was not influenced by the inclusion of other interaction
terms in the analysis
Is the size of the interaction effect large?
No, the size of the effect is less than half of the minimum clinically
important difference for the SF-12 PCS
Is the interaction consistent across studies?
Not applicable, as no other studies have evaluated this interaction
Is the interaction consistent across closely related outcomes within this
No, this interaction was not observed for the SF-12 MCS or the EQ-5D
study?
index score. Also, no interaction was observed between pressure and
solution for the primary study outcome of reoperation within 12
months
Is there indirect evidence that supports the hypothesized interaction
No, there is no biological rationale for the observed interaction
(biological rationale)
*Adapted from criteria developed to evaluate the credibility of subgroup analyses17,18
HRQL, health-related quality of life; EQ-5D, EuroQol-5 Dimensions

returned to baseline at one year or at five years postinjury.20 Several other studies in the literature reflect this.21-

23

A strength of our study is its large, multicentre, randomized controlled nature, with a sample size that exceeds
the a priori calculation, and its use of standardized, validated outcome measures. This is one of the largest studies
to date of its kind and the inclusion of over 40 clinical sites
in five countries increases the ability to generalize from our
results.
VOL. 100-B, No. 1, JANUARY 2018

Despite these strengths, our study has several limitations.
The method of recording pre-injury quality of life may be
prone to recall bias, although previous research has suggested that the level of bias is minimal.24 We did not include
any anatomical- or disease-specific outcome measures; typically, these do not provide such granular data on the global
effect on HRQL and add a significant documentation burden to a trial enrolling patients with potentially diverse patterns of injury. This can, in turn, affect recruitment and
retention rates.
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This study may also be limited by its follow-up.
Although one year is a frequently used follow-up period in
fracture research, it may be insufficient to evaluate recovery
fully. We were able to include 76% of patients enrolled in
the FLOW study in this analysis; while this demonstrates a
not insignificant loss to follow-up, this is a comparable proportion with that seen in previous orthopaedic trauma trials.19
These results show that neither irrigation pressure nor
the composition of the solution have an effect on patients’
HRQL within 12 months of open fracture. Despite modern
fracture implants and high-quality care, patients are not
returning to pre-injury status within 12 months. This can
guide both surgeon and patient expectations after open
fracture. It also suggests that factors other than surgical
treatment may be important, and that non-surgical interventions may be necessary to help patients recover.
Future research needs to look beyond surgical technique
and consider the influence of psychological support, social
circumstances and co-morbidity on outcome. Although
generic measures detected decrements in HRQL at one year,
they may not be sufficient to capture the much smaller differences in clinically important outcomes in open fracture
trials. Future methodological research is needed to understand better the assessment of HRQL in patients with open
fractures.
Take home message:
- Irrigation solution and irrigation pressure do not have an
effect on 12-month post-open fracture HRQL.
- Despite the use of modern fracture implants and high-quality surgical
care, patients sustaining open fractures do not return to their pre-injury
HRQL at 12 months post-injury.

Supplementary material
A full list of the FLOW investigators and details of
the funding is available alongside the online version
of this article at www.bjj.boneandjoint.org.uk
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